Tevogen (TVGN) Cash from Investing Activities (2023)
Tevogen Bio Holdings' (TVGN) quarterly Cash from Investing Activities came in at -$133000.0 in Q1 2023.
Tevogen (TVGN) Cash from Investing Activities (2023) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 1 years of Cash from Investing Activities data on file, last reported at -$133000.0 in Q1 2023.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$133000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was -$133000.0 (changed N/A YoY) and the FY2025 annual result came in at -$64439.0, changed N/A from the prior year.
- Cash from Investing Activities was little changed at -$133000.0 in Q1 2023.
- In the past five years, Cash from Investing Activities ranged from a high of -$133000.0 in Q1 2023 to a low of -$133000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Tevogen | 25.62 Mn | 25.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -133,000.00 |
| Mar 31, 2023 | -133,000.00 |